Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

CSPC Pharmaceutical Group Limited CHJTF

Full chart Compare
Set alert

Price alert · CHJTF

All alert types
1.26 USD +0.15 (+13.51%)

At closeOct 30, 2026, 4:00 PM EDT

1.26 Day range 1.26
0.94 52-week range 1.39
YTD
+32.63%
1 year
+28.57%

Financial health

Altman Z-Score

5.49 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 22.4×
FY 2016: 36.6×FY 2017: 38.7×FY 2018: 30.3×FY 2019: 46.0×FY 2020: 21.5×FY 2021: 16.9×FY 2022: 15.2×FY 2023: 12.7×FY 2024: 12.4×FY 2025: 22.4×
FY 2016 5y median 15.2× FY 2025
P/S 3.3×
FY 2016: 6.1×FY 2017: 7.0×FY 2018: 5.4×FY 2019: 7.7×FY 2020: 3.7×FY 2021: 3.4×FY 2022: 3.0×FY 2023: 2.1×FY 2024: 1.9×FY 2025: 3.3×
FY 2016 5y median 3.0× FY 2025
P/B 2.5×
FY 2016: 8.3×FY 2017: 7.1×FY 2018: 6.6×FY 2019: 9.4×FY 2020: 4.2×FY 2021: 3.7×FY 2022: 3.2×FY 2023: 2.2×FY 2024: 1.8×FY 2025: 2.5×
FY 2016 5y median 2.5× FY 2025
P/FCF 21.2×
FY 2016: 48.7×FY 2017: 62.9×FY 2018: 65.6×FY 2019: 103×FY 2020: 17.2×FY 2021: 40.5×FY 2022: 19.2×FY 2023: 32.4×FY 2024: 30.9×FY 2025: 21.2×
FY 2016 5y median 30.9× FY 2025
EV/EBITDA 15.0×
FY 2016: 23.4×FY 2017: 24.8×FY 2018: 20.4×FY 2019: 35.3×FY 2020: 14.4×FY 2021: 12.3×FY 2022: 9.6×FY 2023: 7.4×FY 2024: 7.1×FY 2025: 15.0×
FY 2016 5y median 9.6× FY 2025
EV/Sales 3.1×
FY 2016: 5.9×FY 2017: 6.8×FY 2018: 5.2×FY 2019: 7.5×FY 2020: 3.4×FY 2021: 3.1×FY 2022: 2.7×FY 2023: 1.8×FY 2024: 1.7×FY 2025: 3.1×
FY 2016 5y median 2.7× FY 2025
FCF Yield 4.7%
FY 2016: 2.1%FY 2017: 1.6%FY 2018: 1.5%FY 2019: 1.0%FY 2020: 5.8%FY 2021: 2.5%FY 2022: 5.2%FY 2023: 3.1%FY 2024: 3.2%FY 2025: 4.7%
FY 2016 5y median 3.2% FY 2025

Profitability

Gross Margin 65.6%
FY 2016: 51.0%FY 2017: 60.4%FY 2018: 63.5%FY 2019: 72.0%FY 2020: 75.0%FY 2021: 75.8%FY 2022: 73.5%FY 2023: 70.5%FY 2024: 70.0%FY 2025: 65.6%
FY 2016 5y median 70.5% FY 2025
Operating Margin 15.3%
FY 2016: 21.4%FY 2017: 22.5%FY 2018: 20.7%FY 2019: 20.8%FY 2020: 21.9%FY 2021: 22.4%FY 2022: 22.4%FY 2023: 22.2%FY 2024: 18.8%FY 2025: 15.3%
FY 2016 5y median 22.2% FY 2025
Net Margin 14.9%
FY 2016: 17.0%FY 2017: 17.9%FY 2018: 16.7%FY 2019: 16.8%FY 2020: 17.4%FY 2021: 20.1%FY 2022: 20.1%FY 2023: 17.0%FY 2024: 14.9%FY 2025: 14.9%
FY 2016 5y median 17.0% FY 2025
ROE 11.4%
FY 2016: 23.2%FY 2017: 18.1%FY 2018: 20.5%FY 2019: 20.4%FY 2020: 19.5%FY 2021: 21.6%FY 2022: 20.9%FY 2023: 17.7%FY 2024: 14.3%FY 2025: 11.4%
FY 2016 5y median 17.7% FY 2025
ROIC 8.4%
FY 2016: 18.4%FY 2017: 19.8%FY 2018: 19.2%FY 2019: 18.7%FY 2020: 18.7%FY 2021: 18.8%FY 2022: 17.1%FY 2023: 17.2%FY 2024: 12.8%FY 2025: 8.4%
FY 2016 5y median 17.1% FY 2025
ROA 8.1%
FY 2016: 14.2%FY 2017: 15.4%FY 2018: 13.3%FY 2019: 14.3%FY 2020: 14.5%FY 2021: 16.2%FY 2022: 14.9%FY 2023: 12.7%FY 2024: 10.4%FY 2025: 8.1%
FY 2016 5y median 12.7% FY 2025

Growth (YoY)

Revenue -12.6%
FY 2016: 8.6%FY 2017: 25.0%FY 2018: 36.0%FY 2019: 5.0%FY 2020: 12.9%FY 2021: 11.9%FY 2022: 10.9%FY 2023: 11.8%FY 2024: -16.2%FY 2025: -12.6%
FY 2016 FY 2025
Operating Income -29.1%
FY 2016: 22.3%FY 2017: 31.4%FY 2018: 25.0%FY 2019: 5.7%FY 2020: 18.8%FY 2021: 14.5%FY 2022: 10.7%FY 2023: 10.9%FY 2024: -29.0%FY 2025: -29.1%
FY 2016 FY 2025
EPS (diluted) -10.8%
FY 2016: 20.0%FY 2017: 33.3%FY 2018: 29.2%FY 2019: 0.0%FY 2020: 16.1%FY 2021: 30.6%FY 2022: 10.6%FY 2023: -5.8%FY 2024: -24.5%FY 2025: -10.8%
FY 2016 FY 2025
Free Cash Flow 128.8%
FY 2016: 30.3%FY 2017: 11.6%FY 2018: -0.7%FY 2019: -3.2%FY 2020: 223.8%FY 2021: -56.3%FY 2022: 108.8%FY 2023: -53.4%FY 2024: -23.7%FY 2025: 128.8%
FY 2016 FY 2025

Financial Health

Current Ratio 2.2×
FY 2016: 2.1×FY 2017: 2.4×FY 2018: 1.9×FY 2019: 2.2×FY 2020: 2.5×FY 2021: 2.8×FY 2022: 2.7×FY 2023: 2.6×FY 2024: 2.3×FY 2025: 2.2×
FY 2016 5y median 2.6× FY 2025
Quick Ratio 1.9×
FY 2016: 1.6×FY 2017: 1.9×FY 2018: 1.5×FY 2019: 1.8×FY 2020: 2.2×FY 2021: 2.5×FY 2022: 2.4×FY 2023: 2.3×FY 2024: 1.9×FY 2025: 1.9×
FY 2016 5y median 2.3× FY 2025
Debt / Equity 0.0×
FY 2016: 0.1×FY 2017: 0.1×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -1.0×
FY 2016: -0.7×FY 2017: -1.0×FY 2018: -0.8×FY 2019: -0.8×FY 2020: -1.2×FY 2021: -1.1×FY 2022: -1.3×FY 2023: -1.3×FY 2024: -0.9×FY 2025: -1.0×
FY 2016 5y median -1.1× FY 2025
Interest Coverage 103×
FY 2016: 70.9×FY 2017: 156×FY 2018: 58.5×FY 2019: 161×FY 2020: 531×FY 2021: 1000×FY 2022: 278×FY 2023: 297×FY 2024: 133×FY 2025: 103×
FY 2016 5y median 278× FY 2025

Dividends

Dividend Yield 2.9%
FY 2016: 0.9%FY 2017: 0.7%FY 2018: 0.8%FY 2019: 0.6%FY 2020: 1.4%FY 2021: 1.8%FY 2022: 2.2%FY 2023: 4.0%FY 2024: 6.0%FY 2025: 2.9%
FY 2016 5y median 2.9% FY 2025
Payout Ratio 64.3%
FY 2016: 30.9%FY 2017: 26.2%FY 2018: 25.4%FY 2019: 26.0%FY 2020: 29.6%FY 2021: 30.2%FY 2022: 33.8%FY 2023: 51.1%FY 2024: 74.7%FY 2025: 64.3%
FY 2016 5y median 51.1% FY 2025

Annual · latest fiscal year ends 2025-12-31